Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
03:49:00 EDT Sat 20 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:CELZ from 2023-04-20 to 2024-04-19 - 16 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-03-27 09:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Provides Corporate Update
2024-03-07 09:15
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
2024-03-06 07:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
2023-12-20 09:36
U
U:CELZ
News Release
200
Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
2023-11-15 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Provides Corporate Update
2023-10-10 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine ‚ ® using AlloStem ¢ „ ¢ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
2023-09-19 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine ‚ ® using AlloStem ¢ „ ¢ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
2023-08-24 10:50
U
U:CELZ
News Release
200
What Is Allogeneic Cell Therapy, And What ¢ € ™s Driving This Market ¢ € ™s 25%+ Annual Global Growth?
2023-07-13 09:02
U
U:CELZ
News Release
200
Creative Medical Technology Reports Advancements In Regenerative Medicine And Improvements In Financial Position In Corporate Update
2023-06-28 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements
2023-06-12 08:01
U
U:CELZ
News Release
200
Creative Medical Technology Announces $2 Million Share Repurchase Program
2023-06-12 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Provides Corporate Update
2023-06-09 12:30
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Announces Reverse Stock Split
2023-05-31 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz ‚ ® Immunotherapy Platform
2023-05-22 08:30
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Announces Next Milestone Achievements in ImmCelz ‚ ® Platform Development
2023-05-18 08:00
U
U:CELZ
News Release
200
Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine ‚ ® Procedure Using AlloStem ¢ „ ¢ Allogenic Cell Line